Edition:
India

Australian Pharmaceutical Industries Ltd (API.AX)

API.AX on Australia Stock Exchange

1.29AUD
24 May 2019
Change (% chg)

$0.00 (+0.39%)
Prev Close
$1.29
Open
$1.29
Day's High
$1.32
Day's Low
$1.28
Volume
935,634
Avg. Vol
1,409,571
52-wk High
$1.95
52-wk Low
$1.25

Latest Key Developments (Source: Significant Developments)

Australian Pharma Industries HY Net Profit After Tax Attributable falls slightly
Wednesday, 17 Apr 2019 

April 17 (Reuters) - Australian Pharmaceutical Industries Ltd ::HY REVENUE FROM ORDINARY ACTIVITIES $1.98 BILLION VERSUS $2.01 BILLION.HY NET PROFIT AFTER TAX ATTRIBUTABLE $24.2 MILLION VERSUS $24.9 MILLION.  Full Article

Australian Pharmaceutical Industries Updates On Sigma Takeover
Wednesday, 13 Mar 2019 

March 13 (Reuters) - Australian Pharmaceutical Industries Ltd ::CLEAR THAT API'S NBIO TO PURSUE A MERGER OF API AND SIGMA IS UNABLE TO BE TAKEN FORWARD.IS REVIEWING ITS SHAREHOLDING IN SIGMA WHICH IT ACQUIRED IN LATTER PART OF 2018.API HAS CLOSED ITS DATA ROOM AND IS REVIEWING ITS SHAREHOLDING IN SIGMA WHICH IT ACQUIRED IN LATTER PART OF 2018.  Full Article

Medlab Clinical Signs Agreement Reached With Australian Pharmaceutical Industries
Wednesday, 30 Jan 2019 

Jan 30 (Reuters) - Medlab Clinical Ltd ::AGREEMENT REACHED WITH AUSTRALIAN PHARMACEUTICAL INDUSTRIES TO CORE RANGE CO'S NUTRACEUTICAL RANGE IN ITS PRICELINE PHARMACY NETWORK.API WILL ALSO HOLD MEDLAB PRODUCTS IN ITS WAREHOUSES AS PART OF AGREEMENT.  Full Article

Sigma Healthcare Notes Australian Pharmaceutical Industries Announcement Of Proposal For Co
Friday, 14 Dec 2018 

Dec 14 (Reuters) - Sigma Healthcare Ltd ::NOTES AUSTRALIAN PHARMACEUTICAL INDUSTRIES ANNOUNCEMENT REGARDING ITS 12.95% STAKE IN COMPANY AND PROPOSAL FOR SIGMA.SIGMA SHAREHOLDERS DO NOT NEED TO TAKE ANY ACTION IN RELATION TO INDICATIVE PROPOSAL.SIGMA REMAINS READY TO CONTINUE THE DISCUSSIONS.  Full Article

Australian Pharmaceutical Industries Sees HY Net Profit After Tax Of $26.5 Million, Down 9 Percent
Wednesday, 24 Jan 2018 

Jan 24 (Reuters) - Australian Pharmaceutical Industries Ltd ::SEES HY‍ NET PROFIT AFTER TAX OF $26.5 MILLION, DOWN 9 PERCENT."‍FORECASTS FULL YEAR PROFIT SHOULD BE MARGINALLY AHEAD OF THAT DELIVERED IN 2017 FINANCIAL YEAR"​.  Full Article

Auscann Group Holdings ‍Enters Agreement With Australian Pharmaceutical Industries
Monday, 22 Jan 2018 

Jan 22 (Reuters) - Auscann Group Holdings Ltd ::‍ENTERS AGREEMENT WITH AUSTRALIAN PHARMACEUTICAL INDUSTRIES LTD.  Full Article

Australian Pharmaceutical Industries Expects FY NPAT To Be Marginally Above That Of FY17​
Monday, 22 Jan 2018 

Jan 22 (Reuters) - Australian Pharmaceutical Industries Ltd ::FY NPAT EXPECTED TO BE MARGINALLY ABOVE THAT OF FY17​.EXPECTS HALF YEAR NET PROFIT AFTER TAX (NPAT) FOR PERIOD ENDING 28 FEB 2018 TO BE ABOUT $26.5 MILLION.  Full Article

Australian Pharmaceutical Industries posts ‍FY profit for period attributable to members $52.371 mln
Thursday, 19 Oct 2017 

Oct 19 (Reuters) - Australian Pharmaceutical Industries Ltd :‍FY profit for period attributable to members $52.371 million versus $51.670 million​.FY ‍revenue from ordinary activities $4.06 billion versus $3.84 billion.Declared ‍final dividend of 3.5 cents​.Expects recent trend in consumer sentiment & discretionary spending will not see reversal in current year​‍​.  Full Article

KKR says invests in Laser Clinics Australia in partnership with The Growth Fund
Friday, 1 Sep 2017 

Sept 1 (Reuters) - KKR & Co - :KKR invests in Laser Clinics Australia in partnership with The Growth Fund.Will acquire a majority stake in LCA and existing investor The Growth Fund will retain a minority stake in the company.Further details of the transaction are not disclosed.  Full Article

Australian Pharmaceutical Industries says it withdrew from process for acquisition of Laser Clinics Australia
Monday, 28 Aug 2017 

Aug 28 (Reuters) - Australian Pharmaceutical Industries Ltd :It withdrew from process for potential acquisition of Laser Clinics Australia..  Full Article

Australia's Sigma Healthcare board rejects API takeover bid

Australian pharmacy operator Sigma Healthcare Ltd's board on Wednesday rejected a A$727 million ($514.5 million) takeover bid from Australian Pharmaceutical Industries Ltd (API) , saying it was not in the best interests of shareholders.